Qi-Ying Hu

Company: Corti Therapeutics

Job title: Chief Executive Officer

Seminars:

Benchmarking Delivery to Novel Organs Without Compromising Safety 3:30 pm

Building and engineering surface modifications to LNPs to target new organize while evading the immune system Harnessing antibody conjugates to guide LNPs to target organ site while mitigating accumulation in off-target organs Developing natural conjugates to prevent chemical residues and resultant toxicityRead more

day: Conference Day Two